The International Society for Pharmacoeconomics and Outcomes Research (ISPOR)’s Value in Health journal published a themed collection of articles on COVID-19 economic outcomes. Although nonpharmaceutical interventions including social restrictions were necessary to reduce the spread of the SARS-CoV-2 virus, these interventions led to widespread economic burden. The series includes reports on cost-effective pharmaceutical interventions, such as recently developed vaccines.
The authors remark, “Understanding the effectiveness and cost-effectiveness of these interventions can maximize the benefits of allocating the limited resources available to tackle the COVID-19 pandemic,” adding,“Collectively, 11 articles in these 2 sections present important data and information on the cost-effectiveness, affordability, and impact of different COVID-19 interventions that can help further optimize the balance between prevention and treatment for societies around the globe.” Read more here.
(Chhatwal & Postma, ISPOR, 2021)